Quince Therapeutics regains compliance with Nasdaq listing requirements

Markets Investing.com By Investing.com 21 May 2026 22:30 1 min read

Quince Therapeutics regains compliance with Nasdaq listing requirements

Quince Therapeutics regains compliance with Nasdaq listing requirements

Quince Therapeutics regains compliance with Nasdaq listing requirements

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.